Global Health Technology Platform – Proximie – Announces Partnership With Vodafone Business to Increase Access to Surgical Healthcare and Training January 11, 2022
Fosun Pharma and Insilico Medicine Announce a Strategic, AI-driven Drug Discovery and Development Collaboration to Jointly Advance Multiple Targets January 11, 2022
Sana Biotechnology Obtains Exclusive License from National Institutes of Health for CD22 CAR Construct January 11, 2022
Singular Genomics Partners with Lexogen to Enable RNA Library Prep for the G4 Sequencing Platform January 10, 2022
Sana Biotechnology, IASO Biotherapeutics, and Innovent Biologics Announce Non-Exclusive License Agreement for Clinically Validated BCMA CAR Construct January 10, 2022
Laekna Therapeutics and Innovent Biologics obtain IND approval for combination therapy in patients with specific types of solid tumors who have been refractory to treatment with PD-1/PD-L1 inhibitors January 9, 2022
RareCyte® Inc. reports significant 2021 growth of Precision Biology™ Services business and customer uptake of Orion™ Spatial Biology instruments and reagents January 6, 2022
Nomi Health Acquires Artemis Health to Accelerate Transformation of U.S. Healthcare with Actionable Insights January 6, 2022
Insilico Medicine Announces the Nomination of Two Preclinical Candidates for PHD2, 12 Months After Program Initiation January 5, 2022